Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases
Frontiers in Genetics · 12.06.2023 · 14
DOI: 10.3389/fgene.2023.1191159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 12.06.2023. Verfasst von Asuman Gedikbasi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Basic Sciences, Institute of Child Health Istanbul University, Istanbul, Türkiye. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi.
Abstract (Originalsprache)
Background
Mitochondrial diseases are the most common group of inherited metabolic disorders, causing difficulties in definite diagnosis due to clinical and genetic heterogeneity. Clinical components are predominantly associated with pathogenic variants shown in nuclear or mitochondrial genomes that affect vital respiratory chain function. The development of high-throughput sequencing technologies has accelerated the elucidation of the genetic etiology of many genetic diseases that previously remained undiagnosed.
Methods
Thirty affected patients from 24 unrelated families with clinical, radiological, biochemical, and histopathological evaluations considered for mitochondrial diseases were investigated. DNA isolated from the peripheral blood samples of probands was sequenced for nuclear exome and mitochondrial DNA (mtDNA) analyses. MtDNA sequencing was also performed from the muscle biopsy material in one patient. For segregation, Sanger sequencing is performed for pathogenic alterations in five other affected family members and healthy parents.
Results
Exome sequencing revealed 14 different pathogenic variants in nine genes encoding mitochondrial function peptides ( AARS2, EARS2, ECHS1, FBXL4, MICOS13, NDUFAF6, OXCT1, POLG , and TK2 ) in 12 patients from nine families and four variants in genes encoding important for muscle structure ( CAPN3, DYSF, and TCAP ) in six patients from four families. Three probands carried pathogenic mtDNA variations in two genes ( MT-ATP6 and MT-TL1 ). Nine variants in five genes are reported for the first time with disease association: ( AARS2 : c.277C>T/p.(R93*), c.845C>G/p.(S282C); EARS2 : c.319C>T/p.(R107C), c.1283delC/p.(P428Lfs*); ECHS1 : c.161G>A/p.(R54His); c.202G>A/p.(E68Lys); NDUFAF6 : c.479delA/p.(N162Ifs*27); and OXCT1 : c.1370C>T/p.(T457I), c.1173-139G>T/p.(?).
Conclusion
Bi-genomic DNA sequencing clarified genetic etiology in 67% (16/24) of the families. Diagnostic utility by mtDNA sequencing in 13% (3/24) and exome sequencing in 54% (13/24) of the families prioritized searching for nuclear genome pathologies for the first-tier test. Weakness and muscle wasting observed in 17% (4/24) of the families underlined that limb-girdle muscular dystrophy, similar to mitochondrial myopathy, is an essential point for differential diagnosis. The correct diagnosis is crucial for comprehensive genetic counseling of families. Also, it contributes to making treatment-helpful referrals, such as ensuring early access to medication for patients with mutations in the TK2 gene.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Basic Sciences, Institute of Child Health Istanbul University, Istanbul, Türkiye.
- Division of Pediatric Nutrition and Metabolism, Department of Pediatrics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
- Department of Medical Genetics, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
- Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye.
Förderung
- Bilimsel Araştirma Projeleri Birimi, Istanbul Üniversitesi
Zitieren
APA
Gedikbasi, A., Toksoy, G., Karaca, M., Gulec, C., Balci, M. C., Gunes, D., Gunes, S., Aslanger, A. D., Unverengil, G., Karaman, B., Basaran, S., Demirkol, M., Gokcay, G. F., & Uyguner, Z. O. (2023). Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases. Frontiers in Genetics, 14. https://doi.org/10.3389/fgene.2023.1191159
Vancouver
Gedikbasi A, Toksoy G, Karaca M, Gulec C, Balci MC, Gunes D, et al. Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases. Frontiers in Genetics. 2023;14. doi:10.3389/fgene.2023.1191159
BibTeX
@article{Gedikbasi2023,
author = {Gedikbasi, Asuman and Toksoy, Guven and Karaca, Meryem and Gulec, Cagri and Balci, Mehmet Cihan and Gunes, Dilek and Gunes, Seda and Aslanger, Ayca Dilruba and Unverengil, Gokcen and Karaman, Birsen and Basaran, Seher and Demirkol, Mubeccel and Gokcay, Gulden Fatma and Uyguner, Zehra Oya},
title = {Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases},
journal = {Frontiers in Genetics},
year = {2023},
volume = {14},
doi = {10.3389/fgene.2023.1191159}
}
EUVIMED